Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Filing Date
Feb 27, 2019
Document Date
Feb 27, 2019
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.